The price of this share is at 19,61$, Akero Therapeutics Inc is a company created in United States dedicated to Biotechnology: Pharmaceutical Preparations with its highest number of sales in North America. Its Executives are Andrew Cheng (President, Chief Executive Officer & Director), Jonathan Young (Chief Operating Officer & Executive Vice President), Reshma Shringarpure (Vice President-Clinical Research & Medical Affairs), Timothy Rolph (Chief Scientific Officer), William R. White (CFO, Treasurer, EVP & Head-Corporate Development) and its address is 601 GATEWAY BOULEVARD SUITE 350, SOUTH SAN FRANCISCO, California, 94080, United States.
The closing price of the stock yesterday was desconocido$.
The current range on the same day is from 19,31$ - 20,01$, with a percentage difference of 19,66$ quite wide that helps to be able to do day trading.
He earns an annual income of desconocido.
The last registered opening is of desconocido.
One of the most interesting values to assess whether the price of a share is low or high is the minimum and maximum price of the last 52 weeks, in this case it has varied between 0,00$ and 0,00$.
Earnings per share, or EPS, is a value also used to assess whether a company has obtained sufficient net profits for the number of shares it has for sale. In this case it is [BPA], but it must be taken into account that there may have been increases or decreases in capital that influence the value.
Buscar
